- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03981965
FOCUS Guidelines and Adherence to Physical Activity in Ageing Women.
Impact of FOCUS Guidelines on Adherence to Physical Activity in Ageing Women.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The objectives of the study consisted of assessing i) whether the use of the Guidelines derived from the European project FOCUS had an effect on the adherence to a physical activity (PA) program (primary objective), and ii) the effect of the program, which included 2 h/week of PA, on a group of dimensions related with general health, frailty, psycho-cognitive parameters, and quality of life (QoL) (secondary objectives).
The study comprised 24 weeks in which a group of 90 postmenopausal women were randomised to three arms, two in which participants were performing PA, and one control (no intervention).
The first PA group followed the FOCUS guidelines, in which women received monthly health talks and had an internet mailbox to facilitate contact with health professionals.
The PA program consisted of a twice per week 1-hour session along 24 weeks. This period was divided into two parts, a first supervised phase in which women followed group sessions under direct supervision of a monitor, and a second period in which the groups of women followed the same exercise pattern, but autonomously. A mobile phone support system (social network whatsapp) was used for inter-connection and mutual support during the autonomous period. Assessments were performed at baseline and then at 12 weeks and 24 weeks, representing the completion of the supervised and the autonomous periods, respectively.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Valencia, España, 46010
- Hosp Clinico Universitario-INCLIVA
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
Community living postmenopausal women capable of performing the physical activity program and with ability to sign the informed consent.
Exclusion Criteria:
Physical or psychological deficiencies incapacitating subjects to participate in the established physical program.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Focus guidelines
Participants enrolled in a 2-phase physical activity program divided in 2 phases as described above. Briefly, The activity consisted in a 1-h set of exercises twice per week. The first 12-week phase was performed in group under the direct supervision of a health monitor. The second 12-week phase was autonomous, and consisted of the same physical performance while maintaining virtual link through a social network based on the mobile phone. The FOCUS guidelines provided 2 features, the participation in monthly health talks provided by the principal investigator and the availability of a virtual mailbox to transmit any comment or suggestion. |
Physical activity as described previously.
|
|
Comparador activo: Active group
Participants enrolled in a 2-phase physical activity program divided into 2 phases as described above.
This group lacked the monthly talks and did not have access to the virtual mailbox.
|
Physical activity as described previously.
|
|
Sin intervención: Inactive
Women of similar clinical characteristic who did not participate in the PA program.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Adherence: Level of adherence to the program as assessed by attendance to the physical activity sessions.
Periodo de tiempo: 6 months
|
Attendance will be measured as a percentage of the total number of sessions.
|
6 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Frailty: changes in frailty as assessed by the Fried index
Periodo de tiempo: 6 months
|
Changes in frailty as assessed by the Fried index, which has 5 dimensions and describes a robust state (negative for all the three criteria) in addition to the pre-frail (positive for 1 or 2 criteria) and frail (positive at least in 3 criteria) status.
|
6 months
|
|
Cognitive function
Periodo de tiempo: 6 months
|
Measures as per ACE-III questionnaire
|
6 months
|
|
Mood status
Periodo de tiempo: 6 months
|
Measures as per HAD questionnaire
|
6 months
|
|
Social activities
Periodo de tiempo: 6 months
|
Measures as per Saint Louis questionnaire
|
6 months
|
|
Psychological well-being as measured by the 52-item Ryff scale
Periodo de tiempo: 6 months
|
The Ryff scale includes 52 items designed to measure six constructs of psychological well-being: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance.
Higher total scores indicate higher psychological well-being.
Respondents rate statements on a scale of 1 to 6, where 1 indicates strong disagreement and 6 indicates strong agreement.
|
6 months
|
|
Sleep quality, measured as per Athens Insomnia scale
Periodo de tiempo: 6 months
|
The Athens scale aims at assessing the insomnia symptoms in individuals with sleep disorders.
The scale measures 8 factors, which are intended to measure nocturnal sleep (5 factors) and daytime sleep-related disorders.
Factors are rated from 0 till 3 and the cumulative score gives the final outcome.
A cut-off score of 6 or higher is considered equivalent to the diagnosis of insomnia.
|
6 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Antonio Cano Sánchez, MD, University of Valencia
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- FOCUS_Valencia
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .